NO20044979L - Nye biomaterialer, deres fremstilling og anvendelse - Google Patents

Nye biomaterialer, deres fremstilling og anvendelse

Info

Publication number
NO20044979L
NO20044979L NO20044979A NO20044979A NO20044979L NO 20044979 L NO20044979 L NO 20044979L NO 20044979 A NO20044979 A NO 20044979A NO 20044979 A NO20044979 A NO 20044979A NO 20044979 L NO20044979 L NO 20044979L
Authority
NO
Norway
Prior art keywords
precipitate
components
additional
component
amphilic
Prior art date
Application number
NO20044979A
Other languages
English (en)
Norwegian (no)
Inventor
Gyorgy Lajos Kis
Lajos Szente
Christian Schoch
Jozsef Szejtli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044979L publication Critical patent/NO20044979L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20044979A 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse NO20044979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19
PCT/EP2003/004076 WO2003089008A1 (en) 2002-04-19 2003-04-17 Novel biomaterials, their preparation and use

Publications (1)

Publication Number Publication Date
NO20044979L true NO20044979L (no) 2004-11-16

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044979A NO20044979L (no) 2002-04-19 2004-11-16 Nye biomaterialer, deres fremstilling og anvendelse

Country Status (19)

Country Link
US (3) US20050163853A1 (es)
EP (1) EP1499361B1 (es)
JP (1) JP4648632B2 (es)
KR (1) KR101121675B1 (es)
CN (1) CN1646171B (es)
AU (1) AU2003224099B2 (es)
BR (1) BR0309340A (es)
CA (1) CA2484100C (es)
CO (1) CO5611168A2 (es)
ES (1) ES2392964T3 (es)
IL (1) IL164627A (es)
MX (1) MXPA04010325A (es)
NO (1) NO20044979L (es)
NZ (1) NZ535810A (es)
PL (1) PL215579B1 (es)
PT (1) PT1499361E (es)
RU (1) RU2321597C2 (es)
WO (1) WO2003089008A1 (es)
ZA (1) ZA200407794B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE602005011928D1 (de) * 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
US9121821B2 (en) * 2006-09-04 2015-09-01 National Institute Of Advanced Industrial Science And Technology Process for analyzing sample by capillary electrophoresis method
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
JP4814945B2 (ja) * 2006-09-04 2011-11-16 独立行政法人産業技術総合研究所 キャピラリー電気泳動法による試料の分析方法
ES2525257T3 (es) 2009-02-25 2014-12-19 Supratek Pharma, Inc. Composiciones de ciclopolisacárido y de bendamustina
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
JP2013521796A (ja) 2010-03-13 2013-06-13 イーストポンド・ラボラトリーズ・リミテッド 脂肪結合性組成物
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
CA2822995C (en) 2010-12-31 2021-05-11 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
EP2672828B1 (en) * 2011-02-10 2015-04-29 Unilever N.V. Antimicrobial composition
MX356582B (es) 2012-01-18 2018-06-05 Surmodics Inc Recubrimiento para dispositivo medico lubrico con bajo nivel de material particulado.
US11439594B2 (en) * 2012-12-04 2022-09-13 Phosphorex, Inc. Microparticles and nanoparticles having negative surface charges
WO2014186702A1 (en) * 2013-05-17 2014-11-20 Marquette University Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
EP3313364B1 (en) 2015-06-24 2019-10-23 Kao Germany GmbH Hair treatment process
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
DK3528856T3 (da) 2016-10-18 2023-10-16 Univ Marquette Kompositmaterialer, der indeholder strukturelle polymerer og fotoreaktive nitrogenoxidfrigørende midler og anvendelser deraf til sårbandager
US12239948B2 (en) 2019-06-17 2025-03-04 Marquette University Materials based on natural pollen grains and uses thereof
MX2022012532A (es) 2020-04-06 2023-03-15 Eastpond Laboratories Ltd Composiciones y métodos para promover la hidratación celular.
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
WO2023212740A1 (en) * 2022-04-29 2023-11-02 Drexel University Surfactant-impregnated mof-coated fabric for antimicrobial applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (es) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
RU2173172C2 (ru) * 1997-05-05 2001-09-10 Сайдекс Инк. Твердые фармацевтические препараты, содержащие физическую смесь сульфоалкилового эфира циклодекстрина и терапевтического агента
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (en) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
AU2608800A (en) * 1999-01-12 2000-08-01 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
JP4069969B2 (ja) * 2000-05-15 2008-04-02 ザ プロクター アンド ギャンブル カンパニー シクロデキストリンを含む組成物
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
CN1646171A (zh) 2005-07-27
RU2321597C2 (ru) 2008-04-10
NZ535810A (en) 2007-11-30
IL164627A (en) 2009-11-18
JP4648632B2 (ja) 2011-03-09
US20050163853A1 (en) 2005-07-28
CA2484100C (en) 2012-01-03
KR20040103968A (ko) 2004-12-09
AU2003224099B2 (en) 2006-11-09
PL215579B1 (pl) 2013-12-31
HK1073070A1 (en) 2005-09-23
ES2392964T3 (es) 2012-12-17
PL371595A1 (en) 2005-06-27
PT1499361E (pt) 2012-11-22
IL164627A0 (en) 2005-12-18
RU2004133887A (ru) 2005-10-20
US20080299166A1 (en) 2008-12-04
CO5611168A2 (es) 2006-02-28
US20120040901A1 (en) 2012-02-16
ZA200407794B (en) 2006-02-22
EP1499361A1 (en) 2005-01-26
CA2484100A1 (en) 2003-10-30
MXPA04010325A (es) 2005-06-08
AU2003224099A1 (en) 2003-11-03
CN1646171B (zh) 2010-05-26
KR101121675B1 (ko) 2012-03-13
JP2005529879A (ja) 2005-10-06
BR0309340A (pt) 2005-03-08
EP1499361B1 (en) 2012-08-08
WO2003089008A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
NO20044979L (no) Nye biomaterialer, deres fremstilling og anvendelse
BRPI0418622A (pt) plantas auto-processantes e partes de planta
DK1157069T3 (da) Fremgangsmåde til fremstilling af farvede pigmenter
CA3090711A1 (en) Meltable lignin compositions, method for producing them and their uses
Weiss et al. Lignin-based pesticide delivery system
BR0313226A (pt) Uso de agentes de floculação para separar resìduo sólido em substratos de fermentação hidrolisados
WO2005061672A3 (en) Method of decomposition polymer
AU2001274229A1 (en) Polysaccharide based gel
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
BRPI0600409A (pt) processo de produção de enzimas celulolìticas e hemicelulolìticas, utilizando os resìduos de destilação de fermentação etanólica de hidrolisados enzimáticos de materiais (ligno)-celulósicos
BR0008642A (pt) Processo para preparar uma matriz de polìmerode condensação/primeiro polìmero, e, processopara preparar uma matriz de polìmero decondensação/látex
WO2002072862A3 (en) New biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere
WO2008021574A3 (en) Modulating plant carotenoid levels
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
BR9803727A (pt) Tintas biostáveis de base em água e processo para suas preparações.
WO2009134996A3 (en) Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules
Soares et al. Enzymatic and Chemical Approaches for Post‐Polymerization Modifications of Diene Rubbers: Current state and Perspectives
WO2004094434A3 (en) Titanium chelate dispersions
Li et al. Protease‐Mediated Synthesis of Zein Nanofibrils: From Structural Elucidation to Functional Application
NO975791L (no) Fremgangsmåte for fremstilling av spraybare, kationiske biopolymerer
PT1696738E (pt) Processo e meio para o tratamento da superfície de produtos alimentares
AU7250601A (en) Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes
Sharan et al. Citric acid production from pre-treated sugarcane bagasse by Aspergillus niger under solid state fermentation
Hainal et al. Lignin as a carbon source for the cultivation of some Rhodotorula species
Usharani et al. Stabilization of collagen through bioconversion: An insight in protein–protein interaction

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application